2010
DOI: 10.3109/09537104.2010.501640
|View full text |Cite
|
Sign up to set email alerts
|

Use of glycoprotein IIb/IIIa receptor antagonist in prosthetic valve thrombosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2012
2012
2013
2013

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…Glycoprotein2b/3a inhibitors may be considered as an alternative therapy for giant thrombus in LA/LAA. To our knowledge, glycoprotein2b/3a receptor blockers have been used in patients that have undergone percutaneous coronary intervention with a lower rate of bleeding and there are two reports on the successful use of glycoprotein2b/3a inhibitors in patients with mechanical prosthetic valve thrombosis [4,5]. Additionally, Yuce et.…”
mentioning
confidence: 99%
“…Glycoprotein2b/3a inhibitors may be considered as an alternative therapy for giant thrombus in LA/LAA. To our knowledge, glycoprotein2b/3a receptor blockers have been used in patients that have undergone percutaneous coronary intervention with a lower rate of bleeding and there are two reports on the successful use of glycoprotein2b/3a inhibitors in patients with mechanical prosthetic valve thrombosis [4,5]. Additionally, Yuce et.…”
mentioning
confidence: 99%
“…In our view, glycoprotein IIb/IIIa inhibitor infusion might provide an alternative treatment option in this problem. Besides there is an increasing and encouraging evidence regarding noncoronary applications of glycoprotein IIb/IIIa inhibitors such as prosthetic valve thrombus, pulmonary embolism, stroke and right atrial thrombus [3][4][5][6][7][8][9][10]. The potential use of glycoprotein IIb/IIIa inhibitors in these broad spectrum of non-coronary thrombotic conditions need to be tested with randomized studies.…”
mentioning
confidence: 99%